Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

They will. This is huge. Means we are going to Phase 3. Time to ventilation to become primary endpoint for the phase 3 trial. So awesome. This small underpowered trial served it's exact purpose of letting us know if phase 3 is worth it, where we will have enough patients to know if this reduces time in hospital and time to ventilation. They will be in talks with big pharma for sure.